Alphamedixtm Phase 2 Data Back New Targeted Alpha Therapy
21 Oct 2025 //
PHARMIWEB
Alphamedixtm Phase 2 Data Back New Targeted Alpha Therapy
20 Oct 2025 //
PRESS RELEASE
Sanofi $110 M Radioligand Therapy Hits Main Goal in Ph. 2 Trial
09 Oct 2025 //
PRESS RELEASE
AlphaMedix (212Pb-DOTAMTATE) Meets Ph2 Endpoints In GEP-NET Study
08 Oct 2025 //
PRESS RELEASE

Market Place
Sourcing Support